These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29512887)

  • 61. [Neurobiology of opioid dependence].
    Scherbaum N; Bonnet U
    Anaesthesist; 2019 Mar; 68(3):179-190. PubMed ID: 30840108
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Circadian clock genes: effects on dopamine, reward and addiction.
    Parekh PK; Ozburn AR; McClung CA
    Alcohol; 2015 Jun; 49(4):341-9. PubMed ID: 25641765
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Addiction-related interactions of pregabalin with morphine in mice and humans: reinforcing and inhibiting effects.
    Vashchinkina E; Piippo O; Vekovischeva O; Krupitsky E; Ilyuk R; Neznanov N; Kazankov K; Zaplatkin I; Korpi ER
    Addict Biol; 2018 May; 23(3):945-958. PubMed ID: 28741741
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Arresting the Development of Addiction: The Role of
    Porter-Stransky KA; Weinshenker D
    J Pharmacol Exp Ther; 2017 Jun; 361(3):341-348. PubMed ID: 28302862
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CART peptide in the nucleus accumbens shell acts downstream to dopamine and mediates the reward and reinforcement actions of morphine.
    Upadhya MA; Nakhate KT; Kokare DM; Singh U; Singru PS; Subhedar NK
    Neuropharmacology; 2012 Mar; 62(4):1823-33. PubMed ID: 22186082
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Structural connectivity of neural reward networks in youth at risk for substance use disorders.
    Squeglia LM; Sorg SF; Jacobus J; Brumback T; Taylor CT; Tapert SF
    Psychopharmacology (Berl); 2015 Jul; 232(13):2217-26. PubMed ID: 25563237
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fear Memory Recall Potentiates Opiate Reward Sensitivity through Dissociable Dopamine D1 versus D4 Receptor-Dependent Memory Mechanisms in the Prefrontal Cortex.
    Jing Li J; Szkudlarek H; Renard J; Hudson R; Rushlow W; Laviolette SR
    J Neurosci; 2018 May; 38(19):4543-4555. PubMed ID: 29686048
    [TBL] [Abstract][Full Text] [Related]  

  • 68. T394A Mutation at the μ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice.
    Wang XF; Barbier E; Chiu YT; He Y; Zhan J; Bi GH; Zhang HY; Feng B; Liu-Chen LY; Wang JB; Xi ZX
    J Neurosci; 2016 Oct; 36(40):10392-10403. PubMed ID: 27707973
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of dronabinol on morphine-induced dopamine-related behavioral effects in animals.
    Mori T; Shibasaki M; Abe M; Udagawa Y; Suzuki T
    Synapse; 2012 Nov; 66(11):931-7. PubMed ID: 22807156
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Opioid reward mechanisms: a key role in drug abuse?
    Herz A
    Can J Physiol Pharmacol; 1998 Mar; 76(3):252-8. PubMed ID: 9673788
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Opiate reward: sites and substrates.
    Wise RA
    Neurosci Biobehav Rev; 1989; 13(2-3):129-33. PubMed ID: 2573023
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Morphine induces conditioned place preference behavior in histidine decarboxylase knockout mice.
    Gong YX; Zhang WP; Shou WT; Zhong K; Chen Z
    Neurosci Lett; 2010 Jan; 468(2):115-9. PubMed ID: 19879332
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus.
    Katsidoni V; Anagnostou I; Panagis G
    Addict Biol; 2013 Mar; 18(2):286-96. PubMed ID: 22862835
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?
    Gondré-Lewis MC; Elman I; Alim T; Chapman E; Settles-Reaves B; Galvao C; Gold MS; Baron D; Kazmi S; Gardner E; Gupta A; Dennen C; Blum K
    Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453620
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neuroimaging of the dopamine/reward system in adolescent drug use.
    Ernst M; Luciana M
    CNS Spectr; 2015 Aug; 20(4):427-41. PubMed ID: 26095977
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Baseline reward circuitry activity and trait reward responsiveness predict expression of opioid analgesia in healthy subjects.
    Wanigasekera V; Lee MC; Rogers R; Kong Y; Leknes S; Andersson J; Tracey I
    Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17705-10. PubMed ID: 23045652
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions.
    Blum K; Bowirrat A; Braverman ER; Baron D; Cadet JL; Kazmi S; Elman I; Thanos PK; Badgaiyan RD; Downs WB; Bagchi D; Llanos-Gomez L; Gold MS
    Int J Environ Res Public Health; 2021 Nov; 18(21):. PubMed ID: 34770047
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Overcoming reward deficiency syndrome by the induction of "dopamine homeostasis" instead of opioids for addiction: illusion or reality?
    Blum K; Soni D; Badgaiyan RD; Baron D
    J Osteopath Med; 2022 Apr; 122(7):333-337. PubMed ID: 35411759
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Substance use disorder a bio-directional subset of reward deficiency syndrome.
    Blum K; Gold M; Demetrovics Z; Archer T; Thanos PK; Baron D; Badgaiyan RD
    Front Biosci (Landmark Ed); 2017 Jun; 22(9):1534-1548. PubMed ID: 28410131
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fifty Years in the Development of a Glutaminergic-Dopaminergic Optimization Complex (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome: A Pictorial.
    Blum K; Febo M; Badgaiyan RD
    Austin Addict Sci; 2016; 1(2):. PubMed ID: 27840857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.